Contact Us

Get 30% Free Customization on This Report

Published Date: August, 2019

Hypertension Drugs Market (Analysis Type - Systemic Hypertension Drugs, and Pulmonary Hypertension Drugs; Therapy Type - Calcium Channel Blockers, Diuretics, Beta Blockers Vasodilators, Angiotensin Converting Enzyme Inhibitor, Alpha Blockers, Angiotensin Receptor Blockers, and Renin Inhibitors; Distribution Channels - Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025


Request Discount Enquire Before Buying

A recent report published by Infinium Global Research on hypertension drugs market provides an in-depth analysis of segments and sub-segments in the global as well as regional hypertension drugs market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional hypertension drugs market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of the global hypertension drugs market. According to the report, the global hypertension drugs market is projected to grow at a CAGR of 3.5% over the forecast period of 2019-2025.

 

Market Insight

Hypertension affects about 75 million Americans, one out of three adults. It is the leading cause of cardiovascular disease, resulting in about 1,000 deaths per day. The current paradigm of managing hypertension is increasing the demand for hypertension drugs over the globe. The overall class of antihypertensive agents lowers blood pressure, although the mechanisms of action vary greatly. Among them, the thiazide diuretics, the ACE inhibitors, the calcium channel blockers, the beta-blockers, and the angiotensin II receptor antagonists or ARBs are the most important and most widely used.

 

The incessantly increasing occurrences of hypertension and growing awareness regarding hypertension management are the major driving factors for the growth of the hypertension drugs market. Uncontrolled high blood pressure raises the risk of heart disease and stroke, which are leading causes of death in the United States. The stressful lifestyle, unhealthy diet, physical inactivity, cigarette smoking, and high intake of alcohol are augmenting the prevalence of hypertension among individuals that are resulting in the growth of the hypertension drugs market. In addition, rising income levels coupled with enhanced medical infrastructure are propelling the growth of the market. Furthermore, with age, there is an increase in blood pressure in the general population. Therefore, the growing elderly population is also anticipated to aid the growth of the hypertension drugs market. However, side effects associated with the continuous use of these drugs is likely to restrain the growth of the hypertension drugs market. Moreover, the expansion of market coverage by multinationals is expected to bring new and emerging opportunities in the hypertension drugs market.

 

Among the regions, North America holds the dominant share in the global hypertension market. The U.S is the key revenue contributor in the North America hypertension market. In addition, high blood pressure affects a huge population in the U.S. Furthermore, high per capita expenditure on healthcare, high disposable income, and reformation in the healthcare system such as reimbursement offerings are contributing to an enormous revenue in the North America hypertension market. Moreover, Asia-Pacific is anticipated to grow at a significant pace over the forecast period owing to increasing occurrences of hypertension, changing dietary habits and sedentary lifestyle trends in emerging markets such as China and India.

 

Segment Covered

The report on global hypertension drugs market covers segments such as analysis type, therapy type, and distribution channels. On the basis of analysis type, the sub-markets include systemic hypertension drugs, and pulmonary hypertension drugs. On the basis of therapy type, the sub-markets include calcium channel blockers, diuretics, beta blockers vasodilators, angiotensin converting enzyme inhibitor, alpha blockers, angiotensin receptor blockers, and renin inhibitors. On the basis of distribution channels, the sub-markets include hospital pharmacy, retail pharmacy, and online pharmacy.

 

Companies Profiled:

The report provides profiles of the companies in the market such as Pfizer, Inc., AstraZeneca plc, Novartis AG, Daiichi Sankyo Company, Ltd., United Therapeutics Corporation, Sanofi S.A., Johnson & Johnson Services, Inc., Boehringer Engelheim GmbH, Takeda Pharmaceutical Company, and Bayer AG.

 

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of hypertension drugs market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.

The Infinium Advantages

Analyst Support

Get free analyst support for the queries before and post purchasing report.

Customer Satisfaction

Be assured of 100% customer satisfaction about the research and get 24X7 customer support.

400% Growth

Infinium has achieved over 400%+ growth in its repository and revenue over the last 2 years. Yes, we are proud to say we are growing at a great pace and becoming a trusted partner among our clients.

Related Reports

sign up for our newsletter